L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock

Keyphrases

• Cardiogenic Shock 100%
• Nitric Oxide Synthase Inhibitors 100%
• L-NMMA 100%
• Mechanical Ventilation 50%
• Mean Arterial Pressure 50%
• Intra-aortic Balloon Pump 50%
• Urine Output 33%
• Cardiac Index 33%
• Catecholamines 33%
• High Dose 16%
• Consecutive Patients 16%
• Adverse Events 16%
• Heart Rate 16%
• Bolus 16%
• Drip 16%
• Clinical Effect 16%
• Coronary Catheterization 16%
• Hemodynamic Effects 16%
• Coronary Revascularization 16%
• Wedge Pressure 16%
• Coronary Intensive Care Unit 16%
• Percutaneous Transluminal 16%

Nursing and Health Professions

• Nitric Oxide Synthase Inhibitor 100%
• N(g) Methylarginine 100%
• Cardiogenic Shock 100%
• Mean Arterial Pressure 50%
• Artificial Respiration 50%
• Intraaortic Balloon Pump 50%
• Urine Volume 33%
• Catecholamine 33%
• Cardiac Index 33%
• Adverse Event 16%
• Drug Megadose 16%
• Coronary Care Unit 16%
• Catheterization 16%
• Heart Muscle Revascularization 16%

Medicine and Dentistry

• Cardiogenic Shock 100%
• Nitric Oxide Synthase Inhibitor 100%
• N(g) Methylarginine 100%
• Artificial Respiration 50%
• Mean Arterial Pressure 50%
• Catecholamine 33%
• Adverse Event 16%
• Drug Megadose 16%
• Hemodynamic 16%
• Coronary Catheterization 16%
• Heart Muscle Revascularization 16%
• Coronary Care Unit 16%